Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1-Mediated Cell Adhesion via the PI3K/AKT Pathway. Xu S, Chen C, Liu H, Jiang S, et al. Mol Carcinog 2025;64:1564-1579.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu S, Chen C, Liu H, Jiang S, et al. Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1-Mediated Cell Adhesion via the PI3K/AKT Pathway. Mol Carcinog 2025;64:1564-1579.
PMID: 40652546